← Leaderboards
Jennifer Louise Whitwell
Mayo Clinic Rochester
$16,907,629
Attributed
$21,064,299
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,064,299 · 7
By mechanism
R01$19,512,485 · 5
RF1$1,192,500 · 1
R21$359,314 · 1
Top collaborators
- Keith A Josephs14 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Keith A Josephs$19,660,217
- Adam L Boxer$75,127,044
- Howard J Rosen$46,265,858
- Rene Lynn Utianski$1,193,160
- Rajeev Srinivas Muthyala$221,925
Others in their field
Top investigators on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Michael W Weiner · Northern California Institute Res &Educ$149,959,854
- David A Bennett · Rush University Medical Center$148,375,056
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$114,442,832
- Hongkui Zeng · Allen Institute$113,960,965
Research focus
BrainFutureNeuroimagingTau ProteinsMagnetic Resonance ImagingPositron-Emission TomographyGrantAutopsyNeurologicDepositionPatternLanguageUptakeProteinsDiffusion Magnetic Resonance ImagingPathologyWhite MatterLigandsDisease ProgressionAffectNerve DegenerationRecruitNeurodegenerative DisordersBiological Markers
Grant awards (40)
Neuroinflammation, white matter integrity, AD biomarkers and pathology in corticobasal syndrome$798,032
R01 · FY2025 · AG · contact PI
Molecular and structural imaging in atypical Alzheimer's disease: a longitudinal study$777,521
R01 · FY2025 · AG · contact PI
Longitudinal multi-modality imaging in non-fluent/agrammatic primary progressive aphasia$684,052
R01 · FY2025 · DC · contact PI
Flortaucipir PET and histopathology in frontotemporal lobar degeneration and Alzheimerâs disease$363,150
R01 · FY2025 · NS
Molecular and structural imaging in atypical Alzheimer's disease: a longitudinal study$792,891
R01 · FY2024 · AG · contact PI
Longitudinal Multi-modal Imaging in Progressive Supranuclear Palsy Syndromes$791,573
R01 · FY2024 · NS · contact PI
Longitudinal multi-modality imaging in non-fluent/agrammatic primary progressive aphasia$684,052
R01 · FY2024 · DC · contact PI
Flortaucipir PET and histopathology in frontotemporal lobar degeneration and Alzheimerâs disease$403,500
R01 · FY2024 · NS
Molecular and structural imaging in atypical Alzheimer's disease: a longitudinal study$793,009
R01 · FY2023 · AG · contact PI
Longitudinal Multi-modal Imaging in Progressive Supranuclear Palsy Syndromes$784,471
R01 · FY2023 · NS · contact PI
Longitudinal multi-modality imaging in non-fluent/agrammatic primary progressive aphasia$699,403
R01 · FY2023 · DC · contact PI
Molecular and structural imaging in atypical Alzheimer's disease: a longitudinal study$793,009
R01 · FY2022 · AG · contact PI
Longitudinal multi-modal imaging in progressive supranuclear palsy syndromes$779,343
R01 · FY2022 · NS · contact PI
Longitudinal multi-modality imaging in progressive apraxia of speech$560,859
R01 · FY2022 · DC · contact PI
Longitudinal multi-modality imaging in progressive apraxia of speech (Diversity Supplement)$11,508
R01 · FY2022 · DC · contact PI
Flortaucipir PET and histopathology in frontotemporal lobar degeneration and Alzheimerâs disease$1,192,500
RF1 · FY2021 · NS
Molecular and structural imaging in atypical Alzheimer's disease: a longitudinal study$806,713
R01 · FY2021 · AG · contact PI
Longitudinal multi-modal imaging in progressive supranuclear palsy syndromes$779,343
R01 · FY2021 · NS · contact PI
Longitudinal multi-modality imaging in progressive apraxia of speech$577,511
R01 · FY2021 · DC · contact PI
Longitudinal multi-modal imaging in progressive supranuclear palsy syndromes$763,277
R01 · FY2020 · NS · contact PI
Longitudinal multi-modality imaging in progressive apraxia of speech$585,460
R01 · FY2020 · DC · contact PI
Molecular and structural imaging in atypical Alzheimer's disease: a longitudinal study$390,778
R01 · FY2020 · AG · contact PI
Longitudinal multi-modality imaging in progressive apraxia of speech$585,460
R01 · FY2019 · DC · contact PI
Molecular and structural imaging in atypical Alzheimer's disease: a longitudinal study$380,322
R01 · FY2019 · AG · contact PI
A molecular anatomic imaging analysis of tau in progressive supranuclear palsy$342,756
R01 · FY2019 · NS
Longitudinal multi-modality imaging in progressive apraxia of speech$554,459
R01 · FY2018 · DC · contact PI
Molecular and structural imaging in atypical Alzheimer's disease: a longitudinal study$372,853
R01 · FY2018 · AG · contact PI
A molecular anatomic imaging analysis of tau in progressive supranuclear palsy$331,518
R01 · FY2018 · NS
Molecular and structural imaging in atypical Alzheimer's disease: a longitudinal study$378,828
R01 · FY2017 · AG · contact PI
Longitudinal multi-modality imaging in progressive apraxia of speech$326,967
R01 · FY2017 · DC · contact PI
A molecular anatomic imaging analysis of tau in progressive supranuclear palsy$324,775
R01 · FY2017 · NS
Molecular and structural imaging in atypical Alzheimer's disease: a longitudinal study$378,828
R01 · FY2016 · AG · contact PI
A molecular anatomic imaging analysis of tau in progressive supranuclear palsy$324,775
R01 · FY2016 · NS
Longitudinal multi-modality imaging in progressive apraxia of speech$312,853
R01 · FY2016 · DC · contact PI
A molecular anatomic imaging analysis of tau in progressive supranuclear palsy$334,327
R01 · FY2015 · NS
Longitudinal multi-modality imaging in progressive apraxia of speech$309,687
R01 · FY2015 · DC · contact PI
Longitudinal multi-modality imaging in progressive apraxia of speech$313,332
R01 · FY2014 · DC · contact PI
Longitudinal multi-modality imaging in progressive apraxia of speech$321,290
R01 · FY2013 · DC · contact PI
An Investigation Into Atypical Alzheimer's Disease$154,457
R21 · FY2011 · AG · contact PI
An Investigation Into Atypical Alzheimer's Disease$204,857
R21 · FY2010 · AG · contact PI